Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Natarajan Sethuraman sold 1,000 shares of Entrada Therapeutics stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $15.00, for a total transaction of $15,000.00. Following the completion of the transaction, the insider now owns 208,032 shares […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 6% on Monday . The company traded as low as $15.40 and last traded at $15.42. 19,255 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 73,412 shares. The stock had previously closed at $16.41. Wall Street Analyst Weigh […]
Entrada Therapeutics (TRDA) Buy Rating Reiterated at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Entrada Therapeutics (NASDAQ:TRDA) Shares Up 7 5% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Natarajan Sethuraman sold 3,026 shares of Entrada Therapeutics stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $18.00, for a total value of $54,468.00. Following the completion of the transaction, the insider now owns 168,299 shares […]